A tired Victorian terrace in a popular student area of Leeds. The investor had full planning consent for conversion to a 12-bedroom HMO under Article 4 — a more demanding planning route than permitted development, but one that ultimately produces a higher-yielding asset. The challenge was finding development finance that understood HMO valuation methodology and would lend against the completed HMO value rather than the lower residential comparable.
We arranged a £1.4 million facility in four weeks — £480,000 for the purchase and £920,000 for the conversion works. Here's how the deal was structured and why the HMO valuation approach was critical.
| Detail | |
|---|---|
| Finance type | Development finance — HMO conversion |
| Total facility | £1,400,000 |
| Site location | Leeds (student rental area, Article 4 zone) |
| Purchase price | £480,000 |
| Land loan | £385,000 (80% of purchase) |
| Conversion facility | £920,000 (staged drawdowns) |
| Developer contribution | £95,000 |
| Projected GDV (HMO basis) | £2,050,000 |
| LTGDV | 68% |
| Profit on GDV | 26% |
| Planning route | Full planning — Article 4 HMO (Sui Generis) |
| Build programme | 7 months |
| Time to completion | 4 weeks |
The core challenge was valuation. A 12-bed HMO in Leeds is not valued on the same basis as a residential dwelling. RICS valuers assess HMOs on a commercial yield basis — typically capitalising the annual rent at a market yield. The problem is that many development lenders default to residential comparable valuation, which would have significantly undervalued the completed asset and compressed the LTGDV to a point where the deal wouldn't stack. The gap between the residential comparable value (£1.6 million) and the HMO investment value (£2.05 million) was £450,000 — enough to make or break the deal.
While full planning was in place, the Article 4 context added a layer of complexity. Lenders needed to see that the planning consent was unconditional, that the HMO licence requirements had been considered, and that the local authority's HMO standards (room sizes, amenity space, fire safety) had been factored into the conversion cost. Some lenders are cautious about Article 4 areas because they perceive the planning risk as higher on future schemes — even when the current consent is clean.
We identified a development lender that specifically values completed HMOs on a commercial yield basis and has a track record of funding HMO conversions in student cities. This was the decisive factor. The lender's internal valuation methodology was aligned with the HMO investment thesis from the outset — no bridging between residential and commercial valuation approaches, no arguments with the valuer about yield assumptions, no haircut on the GDV.
The GDV case was built on three pillars. First, we assembled a rental evidence pack showing achievable per-room rents in the immediate vicinity — £600–£750 per room per month for comparable HMO stock, supported by current listings and three letting agent confirmations. Second, we applied a gross-to-net adjustment reflecting voids, management costs, and maintenance to arrive at a net operating income. Third, we capitalised the NOI at a market yield of 7.5% — conservative for the area, where comparable HMO investment yields trade at 7–8%.
This produced a GDV of £2.05 million — comfortably above the £1.96 million facility plus developer contribution. The LTGDV of 68% was well within the lender's 75% threshold, and the profit on GDV of 26% provided a healthy equity buffer.
The £920,000 conversion facility was structured across four drawdown stages: structural works and fire compartmentation (£280,000), M&E and first fix including en-suite installations (£320,000), second fix and room finishes (£220,000), and external works, kitchens, and snagging (£100,000). Each stage required monitoring surveyor sign-off. The conversion programme was planned at 7 months — fast for a 12-bed scheme, but achievable given the building's sound structural condition and the developer's experience with HMO conversions.
💡 Key point on HMO valuation: The difference between residential comparable valuation and HMO yield-based valuation can be 20-30% on the GDV. If your lender values on residential comparables, your LTGDV will be artificially compressed and your facility may not be sufficient. Identify lenders who use HMO-specific valuation methodology before you submit — this is not something you can negotiate after the valuation is done.
Investor approached us with planning consent and a draft cost schedule. We assembled the rental evidence pack from three local letting agents, calculated the HMO yield-based GDV, and shortlisted two HMO-specialist development lenders.
Full submission including rental evidence, yield analysis, conversion programme, and HMO licence compliance checklist. DIP issued within 3 working days. Valuation instructed on a dual basis — residential comparable and HMO yield.
Valuation confirmed GDV at £2.05 million on HMO basis. Formal offer issued. Legals completed in 7 working days. Purchase completed and first drawdown released.
"The investor had been turned down by two lenders who valued the HMO on residential comparables. The deal was perfectly viable — it just needed a lender who understood that a 12-bed HMO is a commercial investment, not a house. Once we found the right valuation methodology, the deal sailed through."
— MW Capital AdvisoryWe know which lenders value HMOs on a commercial yield basis and which ones don't. If you're planning an HMO conversion, speak to us first — the right lender selection can add 20-30% to your lending headroom.
Discuss Your HMO Project